Zeer GeneDx / intent / genedx

GeneDx

1001-5000 employees·Stamford, Connecticut, United States·genedx.com

Observed, not inferred · updated weekly

Buying intent

151 tracked signals | Top 15 topics are below | Sales and Marketing are carrying most of it.

73signals · 30 days
83topics tracked
72.09%attributed to a team

Attention by team

LinkedIn activity, by team

Where GeneDx's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.

Artificial Intelligence
Hiring
Precision Medicine
Health Care
Healthcare Providers
Digital Health
Sales
High40% of team Sales to Artificial Intelligence: High, 40% of this team's signals
Medium24% of team Sales to Hiring: Medium, 24% of this team's signals
Sales to Precision Medicine: no signal
Low8% of team Sales to Health Care: Low, 8% of this team's signals
Medium20% of team Sales to Healthcare Providers: Medium, 20% of this team's signals
Low8% of team Sales to Digital Health: Low, 8% of this team's signals
Marketing
Low17% of team Marketing to Artificial Intelligence: Low, 17% of this team's signals
Marketing to Hiring: no signal
Low17% of team Marketing to Precision Medicine: Low, 17% of this team's signals
Low17% of team Marketing to Health Care: Low, 17% of this team's signals
Marketing to Healthcare Providers: no signal
Low50% of team Marketing to Digital Health: Low, 50% of this team's signals
Others
Medium42% of team Others to Artificial Intelligence: Medium, 42% of this team's signals
Low8% of team Others to Hiring: Low, 8% of this team's signals
Medium33% of team Others to Precision Medicine: Medium, 33% of this team's signals
Low17% of team Others to Health Care: Low, 17% of this team's signals
Others to Healthcare Providers: no signal
Others to Digital Health: no signal
LowMediumHigh·  banded against the busiest pairing on this page

Topics being researched

30-day window

Every tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.

Artificial Intelligence
LinkedIn
High volume
94%
last
10d ago
Hiring
LinkedIn
Medium volume
94%
last
9d ago
Precision Medicine
LinkedIn
Low volume
97%
last
17d ago
Health Care
LinkedIn
Low volume
94%
last
10d ago
Healthcare Providers
LinkedIn
Low volume
94%
last
10d ago
Digital Health
LinkedIn
Low volume
98%
last
10d ago
Healthcare Interoperability
LinkedIn
Low volume
98%
last
12d ago
Career Development
LinkedIn
Low volume
97%
last
13d ago
Drug Development
LinkedIn
Low volume
98%
last
19d ago
Healthcare Professionals
LinkedIn
Low volume
96%
last
10d ago
Patient Advocacy
LinkedIn
Low volume
98%
last
17d ago
AI Governance
LinkedIn
Low volume
98%
last
18d ago
Digital Transformation
LinkedIn
Low volume
98%
last
18d ago
Gene Therapy
LinkedIn
Low volume
93%
last
9d ago
Business Outcomes
LinkedIn
Low volume
98%
last
18d ago

Need intent for a specific topic or industry?

We track the full taxonomy across every account in the graph — including themes not shown on this page.

Talk to us

Who's active at GeneDx

verified title on file

Titles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.

Others11 active
Directorresearching Precision Medicine
in
Executiveresearching Drug Development
in
Directorresearching Open Source
in
Executiveresearching Health Plan
in
VPresearching Artificial Intelligence
in
Executiveresearching Patient Advocacy
in
Leadershipresearching Artificial Intelligence
in
researching Artificial Intelligence
in
Market and User Research Manager
researching Operating System
in
+ 1 more in Others
Sales3 active
Program Director, Revenue Cycle Management
Directorresearching Artificial Intelligence
in
Program Director, Revenue Cycle Management
Directorresearching Hiring
in
regional account executive
researching Career Development
in
+ 3 more in Sales
Marketing3 active
Head of Growth Marketing
researching Digital Health
in
Player
Leadershipresearching Artificial Intelligence
in
Senior Director of Corporate Communications
researching Patient Advocacy
in
+ 3 more in Marketing
Support1 active
SVP, Infrastructure
Leadershipresearching Pop-Up
in
+ 1 more in Support
Product1 active
Product Lead - Clinical Indications
researching Genomics
in
+ 1 more in Product

See everyone, not just the first 10

19 people across every department at GeneDx, plus a LinkedIn profile link for each.

Primary products / business lines

LinkedIn company profile

We see a world where every genetic condition is understood, and every patient receives the care they need to live their healthiest life through genomics. ​ GeneDx combines unmatched clinical expertise, advanced technology, and the power of GeneDx Infinity™, the world’s largest rare disease genomic dataset. This unparalleled foundation powers GeneDx’s ExomeDx™ and GenomeDx™ tests – ranked #1 by ex

New capability sought

Employee posts (LinkedIn)

Patient Advocacy; Precision Medicine; Business Model; Clinical Trials; Digital Health; Drug Development; Healthcare Interoperability; MBA Programs

Top accounts researching GeneDx

names withheld on the public page

These are companies whose own people brought up GeneDx unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.

151,426 companies · 839,012 people are researching Artificial Intelligence

GeneDx's own team shows 16 signals on this topic. No one outside GeneDx has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.

  • Hiring75,708 cos · 411,263 people
  • Precision Medicine1,307 cos · 4,297 people
Sign up to see which companies →

Buyer profile

company size · seniority

Company size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.

Unlock the buyer profile

Company-size breakdown and buyer seniority mix for accounts researching GeneDx.

Company size breakdown
Buyer seniority mix

Sign up to learn more

Create an account to explore buyer insights as they become available.

Sign up to learn more →

Buying committee functions

Employee job titles (LinkedIn)

Leadership — 2 people; Sales — 2 people; Engineering — 1 person; Marketing — 1 person; HR / Talent — 1 person; Product — 1 person; IT — 1 person

What's been said

public posts mentioning GeneDx

Up to 9 public excerpts naming GeneDx from the past 365 days, across LinkedIn, Reddit, X, YouTube and other public sources.

LinkedIn

👋👋👋 #ISPORAnnual ! GeneDx is excited to be here. Come and see us at booth #837! We will show you GeneDx Infinity, one of the world’s largest genomic datasets. With Andrew Pollock, PhD , Sindhu Raghunandan, PhD , Colleen Caleshu MSc, LCGC, PhD Candidate , Jessica Merritt , Susan Williams , Amanda Ventrella , Bridget Boelter #ISPOR #ISPOR2026

May 2026
LinkedIn

🚀 Excited for #ISPOR2026 Day 2 - stop by booth #837 to learn about GeneDx Infinity, one of the world's largest genomic datasets!

May 2026
LinkedInDigital Health

#NEWS UPDATE: Today, we’re excited to announce new GeneDx Infinity™ data and tools to fuel biopharma drug discovery, accelerate clinical trials, and advance health economics outcomes research (HEOR). GeneDx Infinity is growing rapidly – adding 30% more genomic tests in 2025 than the prior 24 years combined–and each patient tested contributes more data to Infinity, which now includes: • More than 2.5 million genetic tests, including over 1 million exomes and genomes • More than 1.4 billion clinical datapoints, including clinical notes • More than 8 million mapped phenotypic datapoints • Integrated longitudinal claims data from Komodo Health ’s Research Dataset, spanning 7 years on average and 92% overlap • More than 1.5 million contactable patients, representative of the US News link ⬇️ Stop by our booth #837 for a demo at ISPOR—The Professional Society for Health Economics and Outcomes Research . I'd love to meet you. #ISPORAnnual #ISPOR2026 #RWD #genomics #HEOR

May 2026
LinkedIn

Looking forward to the ISPOR—The Professional Society for Health Economics and Outcomes Research event in Philadelphia next week! Visit the GeneDx team at booth #837 - I'd love to meet you and show you GeneDx Infinity, one of the world's largest genomic datasets, in action. If you're a biopharma or biotech company interested in advancing drug discovery, accelerating clinical trials, or advancing HEOR research, we'd love to meet and discuss how we can help you quickly and efficiently reach your goals. The power of 2.5M genetic tests + 8M mapped phenotypic datapoints + claims deliver an unprecedented opportunity for human genetics to enable actionable discoveries and precision medicine at speed and scale. #ISPORAnnual #ISPOR #GeneDx #precisionmedicine

May 2026
LinkedIn

Important #raredisease technical paper from Joseph Devaney , Britt Johnson, PhD, FACMG , Mike Bamshad, and colleagues at GeneDx and Seattle Children's assessing the use of PacBio HiFi #longread genome sequencing using real-world patient clinical samples. Very high yield (99.6%) across a variety of diagnostically important alterations, with the only 2 'misses' being in the context of mosaicism. Favorable turn around time and low need for supplementary assays, but still work to be done with throughput and COGS.

May 2026
Straight from GeneDx: 6 earnings calls and filings read in full. Leadership's own words on the public record — not analyst commentary.

Strategic priorities

Earnings call; SEC filings

Competitive Advantage; Data asset; Sales Cycle; Customer Segments; Take Note (+1 more)

What changed recently

Earnings call; SEC filings

Competitive Advantage; Data asset; Sales Cycle; Customer Segments; Take Note; Revenue Cycle Management Software

About this data. GeneDx (genedx.com). Department attribution is 72.09%; remaining activity is grouped under Others. Updated 2026-10-03T14:00:03.490Z.

Not yet computedPer-team narrative summaries